recombinant factor ix
Recently Published Documents

TOTAL DOCUMENTS

139
(FIVE YEARS 7)

H-INDEX

22
(FIVE YEARS 0)
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Immune tolerance induction using Fc‐fusion‐protein recombinant factor IX in severe haemophilia B

Haemophilia ◽  
2021 ◽  
Author(s):  
Ali Amid ◽  
Heather Perkins ◽  
Julie Gauthier ◽  
Arnaud Bonnefoy ◽  
Manuel Carcao ◽  
...  
Keyword(s):  
Fusion Protein ◽  
Immune Tolerance ◽  
Tolerance Induction ◽  
Factor Ix ◽  
Severe Haemophilia ◽  
Immune Tolerance Induction ◽  
Haemophilia B ◽  
Fc Fusion Protein ◽  
Recombinant Factor Ix

scholarly journals Recombinant factor IX‐Fc fusion protein in severe hemophilia B: Patient‐reported outcomes and health‐related quality of life

2021 ◽  
Vol 5 (7) ◽  
Author(s):  
Mairead O’Donovan ◽  
Eimear Quinn ◽  
Kate Johnston ◽  
Evelyn Singleton ◽  
Julie Benson ◽  
...  
Keyword(s):  
Patient Reported Outcomes ◽  
Factor Ix ◽  
Severe Hemophilia ◽  
Health Related Quality ◽  
Patient Reported ◽  
Fc Fusion Protein ◽  
Related Quality ◽  
Recombinant Factor Ix ◽  
Health Related

scholarly journals Real‐world outcomes with recombinant factor IX Fc fusion protein (rFIXFc) prophylaxis: Longitudinal follow‐up in a national adult cohort

Haemophilia ◽  
2021 ◽  
Author(s):  
Mairead O'Donovan ◽  
Catherine Bergin ◽  
Eimear Quinn ◽  
Evelyn Singleton ◽  
Sheila Roche ◽  
...  
Keyword(s):  
Fusion Protein ◽  
Real World ◽  
Factor Ix ◽  
Fc Fusion Protein ◽  
Recombinant Factor Ix

Hemostatic Management in an Infant With Neuroblastoma and Severe Hemophilia B With Extended Half-life Recombinant Factor IX Fusion Protein

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Franziska Cuntz ◽  
Hedwig E. Deubzer ◽  
Johannes H. Schulte ◽  
Antje Nimtz-Talaska ◽  
Angelika Eggert ◽  
...  
Keyword(s):  
Fusion Protein ◽  
Half Life ◽  
Factor Ix ◽  
Hemophilia B ◽  
Severe Hemophilia ◽  
Recombinant Factor Ix

A prospective surveillance study in haemophilia B patients following a population switch to recombinant factor IX (nonacog gamma)

Haemophilia ◽  
2021 ◽  
Author(s):  
Evemie Dubé ◽  
Clémence Merlen ◽  
Arnaud Bonnefoy ◽  
Julie Gauthier ◽  
Jean‐François Castilloux ◽  
...  
Keyword(s):  
Factor Ix ◽  
Surveillance Study ◽  
Prospective Surveillance ◽  
Haemophilia B ◽  
Recombinant Factor Ix

Inhibitor development in an elderly patient with severe factor IX deficiency being treated with ALPROLIX, a recombinant factor IX Fc fusion protein

Haemophilia ◽  
2020 ◽  
Author(s):  
Claire Comerford ◽  
Maeve Crowley ◽  
Norma Collins ◽  
Brid Booth‐Fleming ◽  
Annmarie Ryan‐Hall ◽  
...  
Keyword(s):  
Elderly Patient ◽  
Fusion Protein ◽  
Factor Ix ◽  
Inhibitor Development ◽  
Fc Fusion Protein ◽  
Recombinant Factor Ix ◽  
Factor Ix Deficiency

scholarly journals Real‐world data demonstrate improved bleed control and extended dosing intervals for patients with haemophilia B after switching to recombinant factor IX Fc fusion protein (rFIXFc) for up to 5 years

Haemophilia ◽  
2020 ◽  
Vol 26 (6) ◽  
pp. 975-983
Author(s):  
Amy Shapiro ◽  
Ateefa Chaudhury ◽  
Michael Wang ◽  
Miguel Escobar ◽  
Elisa Tsao ◽  
...  
Keyword(s):  
Fusion Protein ◽  
Real World ◽  
Factor Ix ◽  
Real World Data ◽  
World Data ◽  
Haemophilia B ◽  
Fc Fusion Protein ◽  
Recombinant Factor Ix ◽  
Dosing Intervals

Characterisation of recombinant factor IX before and after GlycoPEGylation

2020 ◽  
Vol 588 ◽  
pp. 119654
Author(s):  
Finn Stausholm Nielsen ◽  
Anette Skammelsen Schmidt ◽  
Anne Kroll Kristensen ◽  
Anders Dybdal Nielsen ◽  
Brian Kåre Kristensen ◽  
...  
Keyword(s):  
Factor Ix ◽  
Before And After ◽  
Recombinant Factor Ix
Load More ...
Sign in / Sign up

Export Citation Format

Share Document